Alternative versus matched unrelated donor in adolescents and young adults transplanted for acute myeloid leukemia in first complete remission: A report from the SFGM-TC [0.03%]
匹配无关供者与替代无关供者在青少年及青年人急性髓系白血病首次完全缓解期移植中的比较：SFGM-TC报告
Aude-Marie Fourmont,David Beauvais,Marie Balsat et al.
Aude-Marie Fourmont et al.
Sociodemographic factors and timing of allogeneic hematopoietic stem cell transplantation in myeloproliferative neoplasms [0.03%]
我的eloproliferative肿瘤患者行同种异体造血干细胞移植的时间及社会人口学因素的影响
Allison O Taylor,Joshua S Mercer,Claire I Bradbury et al.
Allison O Taylor et al.
Survey on ICU organization and admission after hematopoietic cell transplantation - a report by IDWP and TCWP of the EBMT [0.03%]
重症监护病房的组织和骨髓移植后入住ICU的调查——EBMT的IDWP和TCWP工作组报告
Joanna Drozd-Sokolowska,Jan Styczynski,Rafael de la Camara Llanza et al.
Joanna Drozd-Sokolowska et al.
Hematopoietic stem cells from organ donors lead to long-term multi-lineage engraftment in NSG mice [0.03%]
人器官捐献造血干细胞能在NSG小鼠中诱导长期多系嵌合现象
Lara M Breyer,Hui Wang,Huihui Ma et al.
Lara M Breyer et al.
Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMT [0.03%]
移植后酪氨酸激酶抑制剂与供者淋巴细胞输注在慢性髓性白血病治疗中的应用：欧洲血液和骨髓移植慢性肿瘤工作组的当代实践调查报告
Alexandros Kanellopoulos,Linda Koster,Hugues de Lavallade et al.
Alexandros Kanellopoulos et al.
The landscape of Allogeneic Haematopoietic Cell Transplantation (allo-HCT) for Chronic Myeloid Leukaemia (CML) remains dynamic with the advent of tyrosine kinase inhibitors (TKIs). There remains an absence of widely agreed evidence-based gu...
Bringing the rare into sight: applications of haploidentical stem cell transplantation in the treatment of rare diseases [0.03%]
化罕见为常见——haplo-identical干细胞移植治疗罕见病的临床应用
Xiao-Di Ma,Zheng-Li Xu,Xiao-Jun Huang
Xiao-Di Ma
Haploidentical haematopoietic stem cell transplantation (haplo-HSCT) has transformed the management of haematological diseases by enabling the use of partially matched family donors, thereby markedly expanding donor availability. Advances i...
Umbilical cord blood transplantation in children with Diamond-Blackfan anemia [0.03%]
婴儿和儿童戴维森-布莱克费恩贫血的干细胞移植治疗研究
Fernanda Volt,Malika Akhoudas,Chantal Kenzey et al.
Fernanda Volt et al.
Diamond-Blackfan anemia (DBA) is a rare inherited bone marrow failure syndrome characterized by macrocytic anemia and physical malformations. The only available curative treatment for patients with DBA is hematopoietic cell transplantation ...
Haploidentical transplantation with post-transplant cyclophosphamide is not inferior to 9/10-MUD transplantation with ATG in patients with myeloid malignancies [0.03%]
haploidentical移植后使用环磷酰胺不劣于供者抗胸腺细胞免疫球蛋白治疗的匹配程度为9/10的MM患者
Andrea Gantner,Svenja Labuhn,Daniel Fürst et al.
Andrea Gantner et al.
The selection of the best available donor is crucial for patients' outcome after allogeneic stem cell transplantation (allo-SCT). In the absence of fully Human leucocyte antigen (HLA) -matched donors, mismatched unrelated donor (9/10-MUD) o...
Immune reconstitution in patients with myelofibrosis conditioned with a non-myeloablative regimen prior to allogeneic stem cell transplantation [0.03%]
非清髓方案预处理的骨髓纤维化患者异基因干细胞移植后的免疫重建
Morten Orebo Holmström,Lia Minculescu,Katrine Nørgaard et al.
Morten Orebo Holmström et al.
Single center evaluation of a composite risk assessment model to predict non-relapse mortality following allogeneic hematopoietic cell transplantation (HCT) [0.03%]
评估同种异基因造血细胞移植(HCT)后预测非复发死亡的综合风险评估模型的单中心研究
Reshma Ramlal,Jongphil Kim,Zachary Thompson et al.
Reshma Ramlal et al.